Other Diseases of Blood and Blood-Forming Organs Active Not Recruiting Phase 2 Trials for Ruxolitinib (DB08877)

Also known as: Disorder hematologic / Disorder blood (NOS) / Blood disorder NOS / Blood disorder / Blood/blood forming organ NOS / Dyscrasia blood (NOS) / Haematological disorders / Hematologic disorder / Hematologic Diseases / Diseases of blood and blood-forming organs, unspecified / Blood dyscrasia / Blood dyscrasia NOS / Disease of blood and blood-forming organs, unspecified / Unspecified diseases of blood and blood-forming organs / Diseases of blood and blood-forming organs, other

IndicationStatusPhase
DBCOND0082202 (Other Diseases of Blood and Blood-Forming Organs)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03041636Ruxolitinib Phosphate in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaTreatment